Indication
High Grade B-cell Lymphoma
3 clinical trials
6 products
Product
Zamtocabtagene AutoleucelClinical trial
A Multi-center Single Arm Phase II Study to Evaluate the Safety and Efficacy of Genetically Engineered Autologous Cells Expressing Anti-CD20 and Anti-CD19 Specific Chimeric Antigen Receptor in Subjects With Relapsed and/or Refractory Diffuse Large B Cell LymphomaStatus: Recruiting, Estimated PCD: 2024-12-31
Product
FludarabineProduct
CyclophosphamideProduct
BendamustineClinical trial
Expanded Access Program (EAP) to Provide Epcoritamab (GEN3013) to Eligible Patients With Relapsed or Refractory Large B-cell LymphomaStatus:
Product
EpcoritamabProduct
Axicabtagene CiloleucelClinical trial
A Phase 1/2 Multicenter Study Evaluating the Safety and Efficacy of KTE-C19 in Adults With Refractory Aggressive Non-Hodgkin LymphomaStatus: Completed, Estimated PCD: 2020-09-10